Literature DB >> 29957509

Low endocan levels are predictive of Acute Respiratory Distress Syndrome in severe sepsis and septic shock.

Alexandre Gaudet1, Erika Parmentier2, Sylvain Dubucquoi3, Julien Poissy4, Thibault Duburcq4, Philippe Lassalle5, Nathalie De Freitas Caires6, Daniel Mathieu2.   

Abstract

PURPOSE: Endocan is a circulating proteoglycan measured at high blood levels during severe sepsis, with a likely lung anti-inflammatory function. The aim of this study was to assess whether paradoxically low endocan levels at Intensive Care Unit (ICU) admission could predict Acute Respiratory Distress Syndrome (ARDS) within 72 h in severe septic patients.
MATERIALS AND METHODS: Patients admitted for severe sepsis in the ICU of a French University Hospital were included in a prospective single-center observational study between October 2014 and March 2016.
RESULTS: 72 patients admitted in ICU for severe sepsis were included. Endocan blood values at inclusion were significantly lower in patients who developed an ARDS at 72 h (p < 0.001). For endocan blood values > 5.36 ng/mL, the adjusted OR for development of ARDS at 72 h was of 0.001 (95% CI 0-0.215; p = 0.011). In our cohort, an endocan value < 2.54 ng/mL predicted ARDS at 72 h with a positive predictive value of 1 (Sp = 1 (95% CI 0.94-1)).
CONCLUSIONS: In a cohort of severe septic patients, we observed that low blood levels of endocan at ICU admission were predictive of ARDS at 72 h.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ARDS; Biomarker; Endothelium; Inflammation; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 29957509     DOI: 10.1016/j.jcrc.2018.06.018

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  10 in total

1. 

Authors:  Clémentine Levy; Nicolas Dognon; Sylvain Normandin; Thibault Duburcq; Alexandre Gaudet
Journal:  Med Intensiva       Date:  2022-05-05       Impact factor: 2.799

2.  Endocan, a Risk Factor for Developing Acute Respiratory Distress Syndrome among Severe Pneumonia Patients.

Authors:  Jun Ying; Danfei Zhou; Tongjie Gu; Jianda Huang
Journal:  Can Respir J       Date:  2019-04-01       Impact factor: 2.409

3.  The complex kinetics of blood endocan during the time course of sepsis and acute respiratory distress syndrome.

Authors:  Alexandre Gaudet; Erika Parmentier; Sylvain Dubucquoi; Julien Poissy; Thibault Duburcq; Lucie Portier; Philippe Lassalle; Nathalie De Freitas Caires; Daniel Mathieu
Journal:  Crit Care       Date:  2019-03-12       Impact factor: 9.097

4.  A systematic review of biomarkers multivariately associated with acute respiratory distress syndrome development and mortality.

Authors:  Philip van der Zee; Wim Rietdijk; Peter Somhorst; Henrik Endeman; Diederik Gommers
Journal:  Crit Care       Date:  2020-05-24       Impact factor: 9.097

5.  Decreased expression of endothelial cell specific molecule-1 in lung tissue in emphysematous mice and stable COPD patients.

Authors:  Yan Zhang; Ping Chen; Shan Cai; Jinhua Li; Yan Chen
Journal:  Iran J Basic Med Sci       Date:  2020-12       Impact factor: 2.699

Review 6.  Endocan in Acute Leukemia: Current Knowledge and Future Perspectives.

Authors:  Håkon Reikvam; Kimberley Joanne Hatfield; Øystein Wendelbo; Roald Lindås; Philippe Lassalle; Øystein Bruserud
Journal:  Biomolecules       Date:  2022-03-24

Review 7.  Endocan, sepsis, pneumonia, and acute respiratory distress syndrome.

Authors:  Nathalie De Freitas Caires; Alexandre Gaudet; Lucie Portier; Anne Tsicopoulos; Daniel Mathieu; Philippe Lassalle
Journal:  Crit Care       Date:  2018-10-26       Impact factor: 9.097

Review 8.  The Role of Endocan in Selected Kidney Diseases.

Authors:  Magdalena Nalewajska; Klaudia Gurazda; Małgorzata Marchelek-Myśliwiec; Andrzej Pawlik; Violetta Dziedziejko
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923

Review 9.  Prognostic and Diagnostic Value of Endocan in Kidney Diseases.

Authors:  Elisabeth Samouilidou; Virginia Athanasiadou; Eirini Grapsa
Journal:  Int J Nephrol       Date:  2022-03-14

10.  The circulatory small non-coding RNA landscape in community-acquired pneumonia on intensive care unit admission.

Authors:  Hina N Khan; Aldo Jongejan; Lonneke A van Vught; Janneke Horn; Marcus J Schultz; Aeilko H Zwinderman; Olaf L Cremer; Marc J Bonten; Tom van der Poll; Brendon P Scicluna
Journal:  J Cell Mol Med       Date:  2021-07-17       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.